Anyagértékelés - CoRAP
Anyagértékelés - CoRAP
Anyagértékelés - CoRAP
If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).
For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.
Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.
- Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
- The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
- When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
- When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
- Contact details of the evaluating Member States are provided for all the substance included.
- Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.
Legend:
Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio
Last updated 13 május 2024. Database contains 402 unique substances/entries.
215-535-7
|
1330-20-7
|
Germany
|
Suspected CMR Suspected Sensitiser Consumer use Cumulative exposure High (aggregated) tonnage High RCR Wide dispersive use |
Withdrawn
|
Details | ||
237-159-2
|
13674-87-8
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
203-929-1
|
112-03-8
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
204-857-3
|
127-68-4
|
Ireland
|
Suspected Reprotoxic Exposure of workers High (aggregated) tonnage |
Withdrawn
|
Details | ||
905-588-0
|
-
|
Germany
|
Suspected Reprotoxic Suspected Sensitiser Other hazard based concern Consumer use Exposure of sensitive populations High (aggregated) tonnage High RCR Wide dispersive use |
Withdrawn
|
Details | ||
905-562-9
|
-
|
Germany
|
Suspected Reprotoxic Suspected Sensitiser Other hazard based concern Consumer use Exposure of sensitive populations High (aggregated) tonnage High RCR Wide dispersive use |
Withdrawn
|
Details | ||
701-241-0, 906-390-7
|
-
|
Italy
|
Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use |
Withdrawn
|
Details | ||
203-686-1
|
109-60-4
|
Ireland
|
Suspected Reprotoxic Other hazard based concern Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use |
Withdrawn
|
Details | ||
201-344-6
|
81-33-4
|
Belgium
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
204-500-1
|
121-82-4
|
Hungary
|
Suspected Carcinogenic Suspected Reprotoxic Exposure of environment Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
225-716-2
|
5026-74-4
|
Denmark
|
Suspected Mutagenic Suspected Sensitiser Consumer use Exposure of workers |
Withdrawn
|
Details | ||
271-846-8
|
68609-97-2
|
Ireland
|
Suspected Mutagenic Sensitiser Other hazard based concern Consumer use Exposure of workers High (aggregated) tonnage |
Withdrawn
|
Details | ||
220-260-0
|
2691-41-0
|
Hungary
|
Suspected Carcinogenic Suspected Reprotoxic Exposure of environment Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
629-767-5
|
1228186-18-2
|
Germany
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
432-520-2
|
232938-43-1
|
Belgium
|
Suspected Reprotoxic Potential endocrine disruptor |
Withdrawn
|
Details | ||
249-535-3
|
29253-36-9
|
Austria
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
701-057-0
|
-
|
Germany
|
Suspected PBT/vPvB Exposure of environment High RCR Wide dispersive use |
Withdrawn
|
Details | ||
272-902-4
|
68919-76-6
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Withdrawn
|
Details | ||
204-399-4
|
120-47-8
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
205-117-2
|
133-66-4
|
Italy
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
278-355-8
|
75980-60-8
|
Sweden
|
Reprotoxic Potential endocrine disruptor |
Withdrawn
|
Details | ||
234-126-4
|
10544-72-6
|
Latvia
|
Suspected Mutagenic Suspected Reprotoxic Exposure of workers High RCR |
Withdrawn
|
Details | ||
214-189-4
|
1112-39-6
|
Belgium
|
Reprotoxic Other hazard based concern Exposure of workers |
Withdrawn
|
Details | ||
233-072-9
|
10028-22-5
|
Lithuania
|
Suspected Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use |
Withdrawn
|
Details | ||
215-150-4
|
1306-38-3
|
Germany
|
Suspected Carcinogenic Suspected Mutagenic Other hazard based concern Cumulative exposure Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
218-747-8
|
2224-33-1
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
245-366-4
|
22984-54-9
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
609-946-4
|
41637-38-1
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Withdrawn
|
Details | ||
204-262-9
|
118-58-1
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
931-292-6
|
308062-28-4
|
Ireland
|
Suspected Reprotoxic Other hazard based concern |
Withdrawn
|
Details | ||
251-020-3
|
32388-55-9
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB |
Withdrawn
|
Details | ||
701-276-1
|
-
|
Estonia
|
CMR Suspected PBT/vPvB Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use |
Withdrawn
|
Details | ||
233-593-1
|
10254-57-6
|
Germany
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
204-633-5
|
123-51-3
|
Poland
|
Suspected Carcinogenic Suspected Reprotoxic Suspected Sensitiser Consumer use Exposure of workers |
Withdrawn
|
Details | ||
264-727-7
|
64194-22-5
|
Slovenia
|
Suspected Carcinogenic Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
242-016-2
|
18127-01-0
|
Sweden
|
Suspected Reprotoxic |
Withdrawn
|
Details | ||
200-657-5
|
67-51-6
|
Spain
|
Reprotoxic High RCR |
Withdrawn
|
Details | ||
221-975-0
|
3302-10-1
|
Spain
|
Suspected Reprotoxic Exposure of workers |
Withdrawn
|
Details | ||
204-263-4
|
118-60-5
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
248-227-6
|
27107-89-7
|
Netherlands
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
200-076-7
|
51-03-6
|
Sweden
|
Potential endocrine disruptor Suspected PBT/vPvB Consumer use Wide dispersive use |
Withdrawn
|
Details | ||
226-866-1
|
5521-31-3
|
Belgium
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
622-542-2
|
3891-98-3
|
Austria
|
Suspected Mutagenic Suspected PBT/vPvB Suspected Sensitiser Consumer use Exposure of environment Exposure of workers |
Withdrawn
|
Details | ||
253-057-0
|
36483-57-5
|
Denmark
|
Suspected Carcinogenic Suspected Mutagenic |
Withdrawn
|
Details | ||
700-604-0
|
947701-81-7
|
Finland
|
Suspected PBT/vPvB Consumer use |
Withdrawn
|
Details | ||
701-029-8
|
-
|
Estonia
|
CMR Sensitiser Consumer use Wide dispersive use |
Withdrawn
|
Details | ||
217-496-1
|
1873-88-7
|
Norway
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
241-867-7
|
17928-28-8
|
Norway
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
247-156-8
|
25640-78-2
|
Germany
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
214-263-6
|
1118-46-3
|
2018
|
France
|
Suspected Mutagenic Suspected Reprotoxic Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage Wide dispersive use |
Suspended
|
Details | |
237-695-7
|
13927-71-4
|
2020
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Exposure of workers |
Suspended
|
Details | |
260-828-5
|
57583-34-3
|
2015
|
Netherlands
|
CMR High (aggregated) tonnage |
Suspended
|
Details | |
229-355-1
|
6486-23-3
|
2019
|
Italy
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Suspended
|
Details | |
228-768-4
|
6358-31-2
|
2019
|
Italy
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Suspended
|
Details | |
215-222-5
|
1314-13-2
|
2017
|
Germany
|
Other hazard based concern Consumer use Exposure of environment Other exposure/risk based concern Wide dispersive use |
Ongoing
|
Details | |
701-028-2
|
-
|
2013
|
France
|
Suspected PBT/vPvB Consumer use Exposure of sensitive populations High (aggregated) tonnage High RCR Wide dispersive use |
Ongoing
|
Details | |
222-020-0
|
3319-31-1
|
2012
|
Austria
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
484-450-7
|
1610350-01-0
|
2019
|
Spain
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
257-573-7
|
51981-21-6
|
2024
|
France
|
Suspected Carcinogenic Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
203-499-5
|
107-52-8
|
2024
|
Spain
|
Suspected PBT/vPvB Consumer use Exposure of environment Wide dispersive use |
Ongoing
|
Details | |
BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499
|
403-080-9
|
92484-48-5
|
2023
|
Spain
|
Suspected PMT/vPvM Other hazard based concern Consumer use Cumulative exposure Exposure of environment Other exposure/risk based concern Wide dispersive use |
Ongoing
|
Details |
939-505-4
|
-
|
2023
|
France
|
Potential endocrine disruptor Exposure of environment |
Ongoing
|
Details | |
700-161-3
|
-
|
2013
|
Netherlands
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
422-270-2
|
163702-08-7
|
2019
|
Spain
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
205-031-5
|
131-57-7
|
2014
|
Denmark
|
Potential endocrine disruptor Cumulative exposure Exposure of environment Exposure of sensitive populations Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
267-636-0
|
67905-17-3
|
2019
|
Belgium
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
221-374-3
|
3081-01-4
|
2012
|
Austria
|
Suspected PBT/vPvB Wide dispersive use |
Ongoing
|
Details | |
251-118-6
|
32588-76-4
|
2017
|
Norway
|
Suspected PBT/vPvB Other hazard based concern Consumer use Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
484-410-9
|
920979-28-8
|
2019
|
Spain
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
212-791-1
|
870-08-6
|
2024
|
Austria
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Ongoing
|
Details | |
202-046-9
|
91-17-8
|
2012
|
Finland
|
Suspected PBT/vPvB High (aggregated) tonnage |
Ongoing
|
Details | |
203-628-5
|
108-90-7
|
2023
|
Netherlands
|
Suspected Mutagenic Suspected Reprotoxic Potential endocrine disruptor Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
308-662-5
|
98171-53-0
|
2023
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Consumer use Exposure of environment Exposure of workers |
Ongoing
|
Details | |
203-372-4
|
106-20-7
|
2019
|
Portugal
|
Suspected PBT/vPvB Exposure of environment |
Ongoing
|
Details | |
810-801-4
|
-
|
2015
|
Netherlands
|
Suspected CMR Suspected PBT/vPvB High (aggregated) tonnage |
Ongoing
|
Details | |
270-128-1
|
68411-46-1
|
2016
|
Germany
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
233-215-5
|
10081-67-1
|
2024
|
Sweden
|
Suspected PBT/vPvB Consumer use Exposure of environment Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
227-033-5
|
5613-46-7
|
2024
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
217-121-1
|
1745-89-7
|
2024
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
244-815-1
|
22174-70-5
|
2024
|
Ireland
|
Suspected Reprotoxic Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
300-340-2
|
93925-38-3
|
2023
|
Sweden
|
Potential endocrine disruptor Consumer use Exposure of environment Exposure of sensitive populations Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
229-419-9
|
6528-34-3
|
2019
|
Italy
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
204-881-4
|
128-37-0
|
2016
|
France
|
Potential endocrine disruptor Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
204-278-6
|
118-79-6
|
2024
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PMT/vPvM Other hazard based concern Exposure of environment Exposure of workers |
Ongoing
|
Details | |
242-895-2
|
19224-29-4
|
2024
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
216-475-4
|
1594-08-7
|
2019
|
Belgium
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
248-607-1
|
27689-12-9
|
2024
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Exposure of workers Wide dispersive use |
Ongoing
|
Details | |
205-739-4
|
149-44-0
|
2026
|
Netherlands
|
Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Exposure of workers High (aggregated) tonnage Wide dispersive use |
Not started
|
Details | |
947-768-1
|
-
|
2025
|
Netherlands
|
Suspected Mutagenic Other hazard based concern Exposure of workers Wide dispersive use |
Not started
|
Details | |
905-459-9
|
-
|
2025
|
France
|
Suspected Reprotoxic Suspected PBT/vPvB Other hazard based concern Exposure of environment Exposure of workers High (aggregated) tonnage |
Not started
|
Details | |
701-246-8
|
-
|
2025
|
Spain
|
Suspected PBT/vPvB Consumer use Exposure of environment Wide dispersive use |
Not started
|
Details | |
701-463-8
|
-
|
2025
|
Spain
|
Suspected PBT/vPvB Consumer use Exposure of environment Wide dispersive use |
Not started
|
Details | |
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
|
273-110-1
|
68938-03-4
|
2025
|
Slovenia
|
Suspected PBT/vPvB Consumer use High (aggregated) tonnage |
Not started
|
Details |
941-303-6
|
-
|
2026
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment |
Not started
|
Details | |
200-467-2
|
60-29-7
|
2025
|
France
|
Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Other hazard based concern Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use |
Not started
|
Details | |
215-609-9
|
1333-86-4
|
2026
|
France
|
Carcinogenic Suspected Reprotoxic Consumer use Cumulative exposure Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use |
Not started
|
Details | |
218-487-5
|
2162-74-5
|
2025
|
Italy
|
Suspected PBT/vPvB Exposure of workers Wide dispersive use |
Not started
|
Details | |
931-700-2
|
-
|
2026
|
France
|
Suspected Reprotoxic Other hazard based concern Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Not started
|
Details | |
202-860-4
|
100-52-7
|
2025
|
France
|
Suspected Mutagenic Consumer use Exposure of workers Wide dispersive use |
Not started
|
Details | |
247-118-0
|
25584-83-2
|
2025
|
France
|
Suspected Carcinogenic Suspected Mutagenic Suspected Sensitiser Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use |
Not started
|
Details | |
CD 28-0132; IRGALUBE 232
|
421-820-9
|
192268-65-8
|
2025
|
Netherlands
|
Suspected PBT/vPvB |
Not started
|
Details |
D-8; DD-8
|
405-520-5
|
95235-30-6
|
2025
|
Belgium
|
Potential endocrine disruptor Other exposure/risk based concern |
Not started
|
Details |
1 - 4.5 moles ethoxylated
|
500-082-2
|
32492-61-8
|
2026
|
France
|
Suspected Mutagenic Potential endocrine disruptor Exposure of environment High (aggregated) tonnage Wide dispersive use |
Not started
|
Details |
202-826-9
|
100-18-5
|
2025
|
France
|
Suspected Reprotoxic Suspected PBT/vPvB Other hazard based concern Exposure of environment Exposure of workers |
Not started
|
Details | |
202-773-1
|
99-62-7
|
2025
|
France
|
Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers |
Not started
|
Details | |
205-288-3
|
137-30-4
|
2012
|
Denmark
|
Potential endocrine disruptor High RCR |
Information requested
|
Details | |
236-675-5
|
13463-67-7
|
2018
|
France
|
Carcinogenic Suspected Mutagenic Other hazard based concern |
Information requested
|
Details | |
203-585-2
|
108-46-3
|
2019
|
France
|
Potential endocrine disruptor High (aggregated) tonnage |
Information requested
|
Details | |
264-848-5
|
64365-17-9
|
2015
|
Finland
|
Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
701-385-4
|
-
|
2021
|
France
|
Suspected Mutagenic Suspected PBT/vPvB High (aggregated) tonnage |
Information requested
|
Details | |
915-730-3
|
-
|
2017
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Exposure of environment High RCR Wide dispersive use |
Information requested
|
Details | |
432-240-0
|
12056-51-8
|
2017
|
France
|
Carcinogenic Exposure of workers |
Information requested
|
Details | |
273-066-3
|
68937-41-7
|
2020
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB |
Information requested
|
Details | |
271-867-2
|
68610-51-5
|
2016
|
Spain
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Information requested
|
Details | |
228-250-8
|
6197-30-4
|
2012
|
France
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
429-320-2
|
24748-23-0
|
2019
|
Netherlands
|
PBT/vPvB |
Information requested
|
Details | |
275-702-5
|
71617-10-2
|
2016
|
Germany
|
Potential endocrine disruptor Consumer use Wide dispersive use |
Information requested
|
Details | |
203-492-7
|
107-46-0
|
2013
|
Norway
|
Suspected CMR Consumer use High (aggregated) tonnage |
Information requested
|
Details | |
404-740-9
|
115895-09-5
|
2016
|
Slovenia
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details | |
248-948-6
|
28299-41-4
|
2014
|
Netherlands
|
Suspected PBT/vPvB High (aggregated) tonnage |
Information requested
|
Details | |
215-175-0
|
1309-64-4
|
2018
|
Germany
|
Carcinogenic Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use |
Information requested
|
Details | |
229-782-3
|
6731-36-8
|
2014
|
Germany
|
Suspected PBT/vPvB |
Information requested
|
Details | |
201-159-0
|
78-93-3
|
2018
|
Sweden
|
Suspected Reprotoxic Potential endocrine disruptor Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Information requested
|
Details | |
258-469-4
|
53306-54-0
|
2020
|
Germany
|
Potential endocrine disruptor Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
700-242-3
|
62037-80-3
|
2017
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details | |
WASOX-VMAC2
|
458-680-3
|
797751-44-1
|
2019
|
Spain
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details |
202-525-2
|
96-69-5
|
2015
|
Austria
|
Suspected CMR Potential endocrine disruptor Suspected PBT/vPvB Sensitiser Consumer use Wide dispersive use |
Information requested
|
Details | |
201-618-5
|
85-60-9
|
2019
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers Wide dispersive use |
Information requested
|
Details | |
220-618-6
|
2835-95-2
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Information requested
|
Details | |
201-240-0
|
79-97-0
|
2021
|
Germany
|
Suspected Reprotoxic Potential endocrine disruptor |
Information requested
|
Details | |
209-711-2
|
591-27-5
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Information requested
|
Details | |
202-627-7
|
98-01-1
|
2022
|
Denmark
|
Suspected Carcinogenic Suspected Mutagenic Exposure of workers High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
201-222-2
|
79-74-3
|
2014
|
Italy
|
Suspected PBT/vPvB High RCR |
Information requested
|
Details | |
202-532-0
|
96-76-4
|
2017
|
Belgium
|
Suspected CMR Potential endocrine disruptor Consumer use Wide dispersive use |
Information requested
|
Details | |
201-236-9
|
79-94-7
|
2015
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
274-581-6
|
70356-09-1
|
2015
|
Germany
|
Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
244-240-6
| CAS no:
21145-77-7
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
216-133-4
| CAS no:
1506-02-1
|
-
|
-
|
2020
|
Germany
|
Potential endocrine disruptor High (aggregated) tonnage |
Information requested
|
Details |
214-946-9
|
1222-05-5
|
2022
|
France
|
Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment |
Information requested
|
Details | |
222-182-2
|
3380-34-5
|
2012
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB High (aggregated) tonnage |
Follow-up
|
Details | |
206-420-2
|
338-83-0
|
2020
|
Belgium
|
Suspected PBT/vPvB Exposure of environment |
Follow-up
|
Details | |
209-909-9
|
597-82-0
|
2016
|
Netherlands
|
Suspected PBT/vPvB |
Follow-up
|
Details | |
202-785-7
|
99-76-3
|
2014
|
France
|
CMR Potential endocrine disruptor Consumer use Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
931-745-8
|
-
|
2014
|
Sweden
|
Suspected PBT/vPvB Exposure of environment High RCR |
Follow-up
|
Details | |
700-992-1
|
-
|
2014
|
Norway
|
Suspected PBT/vPvB Consumer use High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
254-052-6
|
38640-62-9
|
2013
|
Sweden
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
215-713-4
|
1345-04-6
|
2018
|
Germany
|
Suspected Carcinogenic Exposure of workers High RCR Other exposure/risk based concern Wide dispersive use |
Follow-up
|
Details | |
231-146-5
|
7440-36-0
|
2018
|
Germany
|
Suspected Carcinogenic Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use |
Follow-up
|
Details | |
233-135-0
|
10043-01-3
|
2015
|
France
|
Suspected CMR Suspected Sensitiser Consumer use High (aggregated) tonnage High RCR Wide dispersive use |
Follow-up
|
Details | |
215-477-2
|
1327-41-9
|
2015
|
France
|
Suspected CMR High (aggregated) tonnage |
Follow-up
|
Details | |
231-208-1
|
7446-70-0
|
2015
|
France
|
Suspected CMR Exposure of workers High (aggregated) tonnage High RCR |
Follow-up
|
Details | |
246-678-3
|
25155-25-3
|
2015
|
Netherlands
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
249-204-3
|
28768-32-3
|
2013
|
Denmark
|
CMR Wide dispersive use |
Follow-up
|
Details | |
215-925-7
|
1453-58-3
|
2018
|
Belgium
|
Suspected Reprotoxic Potential endocrine disruptor Exposure of environment Wide dispersive use |
Follow-up
|
Details | |
249-820-2
|
29736-75-2
|
2018
|
Germany
|
Suspected Carcinogenic Suspected Reprotoxic Other hazard based concern Exposure of workers |
Follow-up
|
Details | |
204-279-1
|
118-82-1
|
2014
|
Austria
|
Suspected CMR Potential endocrine disruptor Suspected PBT/vPvB Suspected Sensitiser Consumer use Exposure of environment Exposure of workers Wide dispersive use |
Follow-up
|
Details | |
202-707-1
|
98-85-1
|
2019
|
Italy
|
Suspected Carcinogenic Suspected Mutagenic Consumer use Exposure of workers Wide dispersive use |
Follow-up
|
Details | |
400-370-7
|
6196-98-1
|
2021
|
Finland
|
Suspected PBT/vPvB Exposure of environment |
Follow-up
|
Details | |
284-366-9
|
84852-53-9
|
2012
|
Sweden
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
284-325-5
|
84852-15-3
|
2014
|
Spain
|
Suspected PBT/vPvB Consumer use High (aggregated) tonnage Wide dispersive use |
Conclusion under preparation
|
Details | |
202-870-9
|
100-61-8
|
2023
|
Poland
|
Suspected Carcinogenic Suspected Mutagenic Cumulative exposure Exposure of workers High RCR Wide dispersive use |
Conclusion under preparation
|
Details | |
206-354-4
|
330-54-1
|
2014
|
Finland
|
Potential endocrine disruptor Other exposure/risk based concern Wide dispersive use |
Conclusion under preparation
|
Details | |
253-775-4
|
38083-17-9
|
2014
|
Belgium
|
Suspected CMR Consumer use Wide dispersive use |
Conclusion under preparation
|
Details | |
435-790-1
|
297730-93-9
|
2018
|
Spain
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Conclusion under preparation
|
Details | |
204-442-7
|
121-00-6
|
2015
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Consumer use Exposure of sensitive populations Wide dispersive use |
Conclusion under preparation
|
Details | |
203-545-4
|
108-05-4
|
2019
|
Latvia
|
Suspected Reprotoxic Potential endocrine disruptor Suspected Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
231-944-3
|
7779-90-0
|
2013
|
Romania
|
High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
246-677-8
|
25155-23-1
|
2014
|
Italy
|
Suspected PBT/vPvB Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
809-930-9
|
1330-78-5
|
2014
|
Netherlands
|
Suspected PBT/vPvB Other hazard based concern High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
202-908-4
|
101-02-0
|
2013
|
United Kingdom
|
Suspected CMR Potential endocrine disruptor Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
204-112-2
|
115-86-6
|
2017
|
France
|
Potential endocrine disruptor Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
220-449-8
|
2768-02-7
|
2013
|
Sweden
|
Suspected Sensitiser Exposure of sensitive populations Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
214-685-0
|
1185-55-3
|
2013
|
Sweden
|
Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
202-924-1
|
101-20-2
|
2019
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Wide dispersive use |
Concluded
|
Details | |
204-800-2
|
126-73-8
|
2012
|
Hungary
|
CMR Other hazard based concern High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
203-625-9
|
108-88-3
|
2012
|
Finland
|
CMR Other hazard based concern Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
231-302-2
|
7488-55-3
|
2016
|
France
|
Suspected CMR Sensitiser Consumer use High (aggregated) tonnage |
Concluded
|
Details | |
205-286-2
|
137-26-8
|
2014
|
Sweden
|
Potential endocrine disruptor High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
203-726-8
|
109-99-9
|
2013
|
Germany
|
CMR Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
204-825-9
|
127-18-4
|
2013
|
Latvia
|
CMR Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
210-382-2
|
614-45-9
|
2013
|
Italy
|
Sensitiser Consumer use Wide dispersive use |
Concluded
|
Details | |
216-653-1
|
1634-04-4
|
2014
|
France
|
Potential endocrine disruptor High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
203-570-0
|
108-30-5
|
2013
|
Austria
|
Suspected CMR Sensitiser High (aggregated) tonnage High RCR |
Concluded
|
Details | |
231-511-9
|
7601-89-0
|
2015
|
Germany
|
Suspected Carcinogenic Potential endocrine disruptor Other hazard based concern Exposure of workers Wide dispersive use |
Concluded
|
Details | |
231-890-0
|
7775-14-6
|
2016
|
Austria
|
Suspected Carcinogenic Suspected Sensitiser Consumer use Exposure of workers High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
231-836-6
|
7758-19-2
|
2019
|
Hungary
|
Suspected Mutagenic Suspected Reprotoxic Exposure of workers Wide dispersive use |
Concluded
|
Details | |
231-131-3
|
7440-22-4
|
2014
|
Netherlands
|
Other hazard based concern High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
231-545-4
|
7631-86-9
|
2012
|
Netherlands
|
Other hazard based concern Other exposure/risk based concern |
Concluded
|
Details | |
447-780-2
|
-
|
2014
|
Estonia
|
Suspected CMR Suspected PBT/vPvB Exposure of environment Exposure of workers |
Concluded
|
Details | |
700-579-6
|
-
|
2017
|
Netherlands
|
Suspected PBT/vPvB Wide dispersive use |
Concluded
|
Details | |
X4261
|
401-850-9
|
255881-94-8
|
2014
|
Belgium
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details |
203-585-2
|
108-46-3
|
2016
|
Finland
|
Potential endocrine disruptor Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
266-042-9
|
65997-13-9
|
2015
|
Finland
|
Suspected PBT/vPvB Consumer use Exposure of environment High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
807-935-0
|
1244733-77-4
|
2022
|
Denmark
|
Suspected Carcinogenic Suspected Reprotoxic Potential endocrine disruptor Consumer use Cumulative exposure High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
931-384-6
|
-
|
2013
|
Slovenia
|
Suspected PBT/vPvB Consumer use High (aggregated) tonnage |
Concluded
|
Details | |
938-828-8
|
-
|
2021
|
Sweden
|
Suspected Reprotoxic Potential endocrine disruptor Suspected Sensitiser Consumer use Exposure of environment Exposure of workers Wide dispersive use |
Concluded
|
Details | |
ADDITIV 104
|
412-780-3
|
1380226-46-9
|
France
|
Suspected PBT/vPvB |
Concluded
|
Details | |
ROBAC AS/100
|
403-030-6
|
137398-54-0
|
Belgium
|
Suspected PBT/vPvB |
Concluded
|
Details | |
430-050-2
|
-
|
2017
|
Spain
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
905-806-4
|
-
|
2015
|
Estonia
|
CMR Suspected PBT/vPvB Sensitiser Consumer use High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
701-337-2
|
-
|
2020
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Consumer use Exposure of environment Exposure of workers High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |